Related references
Note: Only part of the references are listed.Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria
S. T. R. Zaidi et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Risk Factors for Treatment Failure of Polymyxin B Monotherapy for Carbapenem-Resistant Klebsiella pneumoniae Infections
Yanina Dubrovskaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Nosocomial Pneumonia Lessons Learned
Girish B. Nair et al.
CRITICAL CARE CLINICS (2013)
Clinical and microbiological efficacy and toxicity of colistin in patients infected with multidrug-resistant gram-negative pathogens
Gul R. Yilmaz et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Incidence and Predictors of Nephrotoxicity Associated with Intravenous Colistin in Overweight and Obese Patients
Timothy P. Gauthier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?
Gamze Kalin et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council countries
Mahmoud Aly et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2012)
Device-associated infections rates in adult, pediatric, and neonatal intensive care units of hospitals in the Philippines: International Nosocomial Infection Control Consortium (INICC) findings
Josephine Anne Navoa-Ng et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2011)
Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
Jason M. Pogue et al.
CLINICAL INFECTIOUS DISEASES (2011)
Device-associated infection rates in 398 intensive care units in Shanghai, China: International Nosocomial Infection Control Consortium (INICC) findings
Lili Tao et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)
Nephrotoxicity Associated with Intravenous Colistin in Critically Ill Patients
Neha M Doshi et al.
PHARMACOTHERAPY (2011)
Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients
Argyris S. Michalopoulos et al.
ANNALS OF INTENSIVE CARE (2011)
Antimicrobial Treatment and Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia
Jeannie D. Chan et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2010)
Effectiveness and Safety of Colistin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections
M. Montero et al.
INFECTION (2009)
Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany
E. De Cock et al.
INFECTION (2009)
Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model
M. Bounthavong et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative, bacteria
Vicente Pintado et al.
JOURNAL OF INFECTION (2008)
Nephrotoxicity of intravenous colistin: a prospective evaluation
ME Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Share Paper
